At the end of the latest market close, DermTech Inc. (DMTK) was valued at $6.50. In that particular session, Stock kicked-off at the price of $6.47 while reaching the peak value of $7.37 and lowest value recorded on the day was $6.39. The stock current value is $7.26.Recently in News on May 10, 2022, DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program. DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its commendation and support for the Biden Administration’s reignited Cancer Moonshot program, developed to accelerate the rate of progress against cancer. Recognizing that detecting and diagnosing cancer earlier can pave the way for more effective treatment options, the program outlines specific goals including increased access to cancer screenings and improved patient support. You can read further details here
DermTech Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $17.68 on 01/03/22, with the lowest value was $6.39 for the same time period, recorded on 05/12/22.
DermTech Inc. (DMTK) full year performance was -75.09%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, DermTech Inc. shares are logging -84.98% during the 52-week period from high price, and 13.62% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.39 and $48.32.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1478582 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the DermTech Inc. (DMTK) recorded performance in the market was -54.05%, having the revenues showcasing -46.54% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 227.75M, as it employees total of 255 workers.
Specialists analysis on DermTech Inc. (DMTK)
During the last month, 6 analysts gave the DermTech Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 12.89, with a change in the price was noted -11.63. In a similar fashion, DermTech Inc. posted a movement of -61.57% for the period of last 100 days, recording 739,896 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DMTK is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: DermTech Inc. (DMTK)
Raw Stochastic average of DermTech Inc. in the period of last 50 days is set at 8.75%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 14.08%. In the last 20 days, the company’s Stochastic %K was 7.94% and its Stochastic %D was recorded 5.35%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -54.05%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -72.90%, alongside a downfall of -75.09% for the period of the last 12 months. The shares increased approximately by -10.15% in the 7-day charts and went up by -41.64% in the period of the last 30 days. Common stock shares were lifted by -46.54% during last recorded quarter.